Table 2. The docking energies of VEGF/VEGFR inhibitors .
| Compound | Receptor | DE (kcal/mol) | SE (kT) | VDW (kcal/mol) | EIE (kcal/mol) |
| Stigmasterol | VEGF | -5.6 | -2068.628 | -1.2979 | -0.07277 |
| VEGFR-1 | -3.9 | -8359.984 | -1.1157 | -0.31115 | |
| VEGFR-2 | -3.5 | -5435.427 | -0.0564 | -0.29491 | |
| Apigenin | VEGF | -7.8 | -2096.281 | -3.64048 | -9.65219 |
| VEGFR-1 | -6.1 | -8387.301 | -5.10059 | -4.2378 | |
| VEGFR-2 | -9.4 | -5494.698 | -2.74363 | -5.12448 | |
| Apigenin-7-O-β-glucuronide | VEGF | -9.6 | -2080.67 | -7.73188 | -13.7057 |
| VEGFR-1 | -5.7 | -8352.803 | -9.56820 | -10.9582 | |
| VEGFR-2 | -6.8 | -5488.201 | -10.7391 | -7.47193 | |
| Chlorogenic acid | VEGF | -6.3 | -2090.167 | -7.0811 | -5.61221 |
| VEGFR-1 | -8.9 | -8367.643 | -3.0391 | -7.09720 | |
| VEGFR-2 | -7.6 | -5465.598 | -6.0912 | -9.079410 | |
| Naringin | VEGF | -4.5 | -2057.588 | -3.88656 | -1.193673 |
| VEGFR-1 | -5.6 | -8321.324 | -1.37514 | -2.062841 | |
| VEGFR-2 | -8.9 | -5451.272 | -1.89640 | - 1.170682 | |
| Luteolin | VEGF | -5.9 | -2095.77 | -10.7339 | -6.130221 |
| VEGFR-1 | -5.1 | -8358.241 | -6.7795 | -7.786643 | |
| VEGFR-2 | -7.3 | -5494.300 | -8.7790 | - 5.377954 | |
| Luteolin-7-O-β-glucuronide | VEGF | -5.7 | -2070.673 | -8.90761 | -4.3109123 |
| VEGFR-1 | -7.6 | -83456.129 | -6.27990 | -8.7433921 | |
| VEGFR-2 | -5.2 | -5487.870 | -8.84682 | -2.0008144 | |
| Isorahamentin | VEGF | -6.7 | -2095.413 | -1.29281 | -3.7180134 |
| VEGR-1 | -8.3 | -8367.210 | -5.96710 | -5.2834756 | |
| VEGFR-2 | -5.8 | -5495.932 | -4.83243 | -2.210868 | |
| Ferulic acid | VEGF | -4.3 | -2101.615 | -4.85457 | -3.572598 |
| VEGFR-1 | -7.1 | -8329.320 | -5.03915 | -4.097232 | |
| VEGFR-2 | -7.2 | -5499.175 | -3.77985 | -3.775500 |
DE: docking energy; SE: solvation energy; VDW: Van der Waals; EIE: Electrostatic Interaction Energy.